UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Targeting Transcriptional Enhanced Associate Domains (TEADs)

Journal of medicinal chemistry, 2018-06, Vol.61 (12), p.5057-5072

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-Photoinduced Biological Properties of Verteporfin

Current medicinal chemistry, 2016-01, Vol.23 (11), p.1171

2016

Link zum Volltext

Verfügbarkeit prüfen

The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target

Cell death and differentiation, 2022-02, Vol.29 (2), p.285-292

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway

ChemMedChem, 2017-06, Vol.12 (12), p.954-961

2017

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity

Antiviral research, 2014-08, Vol.108, p.48-55

2014

Link zum Volltext

Verfügbarkeit prüfen

Magnesium Chelating 2-Hydroxyisoquinoline-1,3(2H,4H)-diones, as Inhibitors of HIV-1 Integrase and/or the HIV-1 Reverse Transcriptase Ribonuclease H Domain: Discovery of a Novel Selective Inhibitor of the Ribonuclease H Function

Journal of medicinal chemistry, 2011-03, Vol.54 (6), p.1812-1824

2011

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles

Antiviral research, 2017-07, Vol.143, p.205-217

2017

Link zum Volltext

Verfügbarkeit prüfen

Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders

Cells (Basel, Switzerland), 2022-11, Vol.11 (22), p.3631

2022

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

Journal of medicinal chemistry, 2008-12, Vol.51 (24), p.7717-7730

2008

Link zum Volltext

Verfügbarkeit prüfen

Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet

Current medicinal chemistry, 2005-01, Vol.12 (15), p.1811

2005

Link zum Volltext

Verfügbarkeit prüfen

Patented HIV-1 integrase inhibitors (1998-2005)

Recent patents on anti-infective drug discovery, 2006-01, Vol.1 (1), p.1

Cotelle, Philippe

2006

Link zum Volltext

Verfügbarkeit prüfen

Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)

Expert opinion on therapeutic patents, 2022-08, Vol.32 (8), p.899-912

2022

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis

Bioorganic & medicinal chemistry letters, 2005-11, Vol.15 (22), p.5053-5056

2005

Link zum Volltext

Verfügbarkeit prüfen

The preclinical discovery and development of dolutegravir for the treatment of HIV

Expert opinion on drug discovery, 2015-11, Vol.10 (11), p.1243-1253

2015

Link zum Volltext

Verfügbarkeit prüfen

Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs

Journal of medicinal chemistry, 2022-04, Vol.65 (8), p.5926-5940

2022

Link zum Volltext

Verfügbarkeit prüfen

Oleuropein and derivatives from olives as Tau aggregation inhibitors

Neurochemistry international, 2011-05, Vol.58 (6), p.700-707

2011

Link zum Volltext

Verfügbarkeit prüfen

3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1

Expert opinion on therapeutic patents, 2011-11, Vol.21 (11), p.1799-1804

Cotelle, Philippe

2011

Link zum Volltext

Verfügbarkeit prüfen

Targeting Transcriptional Enhanced Associate Domains (TEADs): Miniperspective

Journal of medicinal chemistry, 2018-06, Vol.61 (12), p.5057-5072

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of a cryptic site at the interface 2 of TEAD – Towards a new family of YAP/TAZ-TEAD inhibitors

European journal of medicinal chemistry, 2021-12, Vol.226, p.113835-113835, Article 113835

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay

Antiviral research, 2022-08, Vol.204, p.105364-105364, Article 105364

2022

Link zum Volltext

Verfügbarkeit prüfen

Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings

Bioorganic & medicinal chemistry letters, 2023-10, Vol.95, p.129488-129488, Article 129488

2023

Link zum Volltext

Verfügbarkeit prüfen

New hexahydrodiazocino-naphthyridine triones as HIV-1 integrase inhibitors: WO2008048538 A1

Expert opinion on therapeutic patents, 2009-01, Vol.19 (1), p.87-93

Cotelle, Philippe

2009

Link zum Volltext

Verfügbarkeit prüfen

Design, Synthesis and Evaluation of a Series of 1,5‐Diaryl‐1,2,3‐triazole‐4‐carbohydrazones as Inhibitors of the YAP‐TAZ/TEAD Complex

ChemMedChem, 2021-09, Vol.16 (18), p.2823-2844

2021

Link zum Volltext

Verfügbarkeit prüfen

Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity

Bioorganic & medicinal chemistry letters, 2012-06, Vol.22 (12), p.3988-3992

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(109)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Targeting Transcriptional Enhanced Associate Domains (TEADs)

Non-Photoinduced Biological Properties of Verteporfin

The NSP14/NSP10 RNA repair complex as a Pan-coronavirus therapeutic target

Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo Pathway

Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity

Magnesium Chelating 2-Hydroxyisoquinoline-1,3(2H,4H)-diones, as Inhibitors of HIV-1 Integrase and/or the HIV-1 Reverse Transcriptase Ribonuclease H Domain: Discovery of a Novel Selective Inhibitor of the Ribonuclease H Function

Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles

Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders

Design, Synthesis, and Biological Evaluation of a Series of 2-Hydroxyisoquinoline-1,3(2H,4H)-diones as Dual Inhibitors of Human Immunodeficiency Virus Type 1 Integrase and the Reverse Transcriptase RNase H Domain

Toward the Discovery of a Novel Class of YAP⁻TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP⁻TEAD Protein⁻Protein Interface

Anti-HIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet

Patented HIV-1 integrase inhibitors (1998-2005)

Progress with YAP/TAZ-TEAD inhibitors: a patent review (2018-present)

Synthesis and HIV-1 integrase inhibitory activities of caffeic acid dimers derived from Salvia officinalis

The preclinical discovery and development of dolutegravir for the treatment of HIV

Toward the Design of Ligands Selective for the C-Terminal Domain of TEADs

Oleuropein and derivatives from olives as Tau aggregation inhibitors

3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1

Targeting Transcriptional Enhanced Associate Domains (TEADs): Miniperspective

Discovery of a cryptic site at the interface 2 of TEAD – Towards a new family of YAP/TAZ-TEAD inhibitors

Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay

Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings

New hexahydrodiazocino-naphthyridine triones as HIV-1 integrase inhibitors: WO2008048538 A1

Design, Synthesis and Evaluation of a Series of 1,5‐Diaryl‐1,2,3‐triazole‐4‐carbohydrazones as Inhibitors of the YAP‐TAZ/TEAD Complex

Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity

Suchergebnisse filtern